Researchers at Washington University in St. Louis have found that two proteins released in urine might be able to help identify 90 percent of kidney cancers. In a study that appears in the journal Mayo Clinic Proceedings, the scientists found that patients with kidney cancer had 10 to 100 times the levels of the proteins aquaporin-1 (AQP1) and adipophilin (ADFP) in their urine than healthy subjects, when urine volume was controlled for…
"The biomarker concentrations of patients with kidney cancer are many, many fold higher, even for patients with some underlying kidney disease," Evan D. Kharasch, Ph.D., M.D., lead author of the study and a professor of anesthesiology at Washington University, tells DOTmed News.
DOTmed News, by Brendon Nafziger, 4/2010
Additional coverage: UPI.com